Ulf D. Kahlert
Papers
2
Total Citations
18
H-Index
2
About
Ulf D. Kahlert is a translational cancer researcher whose work bridges neurosurgical oncology and advanced surgical robotics. His primary research areas include glioblastoma stem cell biology, drug repurposing, and the immunomodulatory effects of minimally invasive surgery. Kahlert’s most notable contribution is the development of a robotic platform to identify Parkinson’s disease therapeutics as repurposed agents targeting glioblastoma stem cells—a high-throughput approach that addresses the urgent need for therapies against this lethal, heterogeneous brain tumor. This landmark 2020 study, which has garnered 16 citations, exemplifies his innovative use of automation to probe the neurotransmitter microenvironment’s role in cancer stem cell hierarchy. More recently, Kahlert has investigated robotic-assisted liver surgery, demonstrating that this technique enhances postoperative immune competence while minimizing systemic inflammation compared to open procedures. His 2025 paper on this topic, though newly published, signals a growing impact in surgical oncology. By integrating robotics with cancer biology, Kahlert is forging a unique path toward precision therapies and improved surgical outcomes, making his work essential reading for researchers at the intersection of oncology, immunology, and surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2